Australia - English - Department of Health (Therapeutic Goods Administration)

swisse wellness pty ltd - magnesium phosphate pentahydrate, quantity: 169.41 mg (equivalent: magnesium, qty 35 mg); zinc amino acid chelate, quantity: 125 mg (equivalent: zinc, qty 25 mg); manganese sulfate monohydrate, quantity: 6.15 mg (equivalent: manganese, qty 2 mg); pyridoxine hydrochloride, quantity: 36.46 mg (equivalent: pyridoxine, qty 30 mg); retinol acetate, quantity: 0.4312 mg (equivalent: vitamin a, qty 0.375 mg) - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; carnauba wax; crospovidone; calcium hydrogen phosphate dihydrate; povidone; croscarmellose sodium; hypromellose; maize starch; gelatin; silicon dioxide; butylated hydroxytoluene; sucrose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - maintain/support general health and wellbeing ; maintain/support smell sensation ; maintain/support taste sensation ; maintain/support immune system health ; maintain/support healthy immune system function ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; maintain/support female reproductive system health ; maintain/support reproductive system health ; maintain/support sperm health ; maintain/support sperm production ; maintain/support testosterone level ; maintain/support skin health ; maintain/support wound healing

Australia - English - Department of Health (Therapeutic Goods Administration)

nutrivital pty ltd - magnesium phosphate pentahydrate, quantity: 150 mg (equivalent: magnesium, qty 30.99 mg; equivalent: phosphorus, qty 26.33 mg); pyridoxine hydrochloride, quantity: 25 mg (equivalent: pyridoxine, qty 20.56 mg); zinc amino acid chelate, quantity: 250 mg (equivalent: zinc, qty 25 mg); chromium nicotinate, quantity: 250 microgram (equivalent: chromium, qty 25 microgram); manganese amino acid chelate, quantity: 2 mg (equivalent: manganese, qty 200 microgram); retinol acetate, quantity: 0.5175 mg (equivalent: vitamin a, qty 0.45 mg) - tablet, film coated - excipient ingredients: titanium dioxide; magnesium stearate; crospovidone; carnauba wax; colloidal anhydrous silica; calcium hydrogen phosphate dihydrate; povidone; microcrystalline cellulose; macrogol 400; hypromellose; maize starch; gelatin; silicon dioxide; butylated hydroxytoluene; sucrose - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support energy levels ; maintain/support healthy eye function ; maintain/support eye health ; maintain/support healthy eyesight/vision ; maintain/support body mucous membrane health ; maintain/support general health and wellbeing ; maintain/support hair health ; maintain/support nail health/strength/thickness ; maintain/support bone health ; aid/assist healthy red blood cell production ; maintain/support immune system health ; maintain/support healthy immune system function ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; aid/assist/helps protein synthesis in the body ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; maintain/support cognitive function/mental function ; maintain/support nerve conduction ; maintain/support nervous system health ; maintain/support nervous system function ; maintain/support female reproductive system health ; maintain/support reproductive system health ; maintain/support healthy reproductive hormones ; maintain/support skin health ; maintain/support skin regeneration

Australia - English - Department of Health (Therapeutic Goods Administration)

fit-bioceuticals pty ltd - magnesium phosphate pentahydrate, quantity: 122 mg (equivalent: magnesium, qty 25.2 mg); manganese amino acid chelate, quantity: 20 mg (equivalent: manganese, qty 2 mg); zinc amino acid chelate, quantity: 125 mg (equivalent: zinc, qty 25 mg); pyridoxine hydrochloride, quantity: 50 mg (equivalent: pyridoxine, qty 41.1 mg); retinol acetate, quantity: 0.8625 mg (equivalent: vitamin a, qty 0.75 mg) - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; titanium dioxide; microcrystalline cellulose; carnauba wax; purified talc; hypromellose; macrogol 400; maize starch; gelatin; silicon dioxide; butylated hydroxytoluene; sucrose - antioxidant/reduce free radicals formed in the body ; maintain/support healthy eyesight/vision ; maintain/support healthy growth and development ; helps maintain/support healthy blood sugar/glucose ; maintain/support healthy immune system function ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; aid/assist/helps protein synthesis in the body ; maintain/support nerve conduction ; aid/assist/helps synthesis of neurotransmitters ; maintains/support healthy foetal development ; maintain/support healthy pregnancy ; helps maintain/support testosterone formation/synthesis ; help maintain/support healthy prostate function ; maintain/support sperm health ; maintain/support skin health ; maintain/support wound healing

Australia - English - Department of Health (Therapeutic Goods Administration)

pro ma systems aust pty ltd - ascorbic acid,biotin,calcium citrate,calcium pantothenate,choline bitartrate,chromium picolinate,colecalciferol,copper gluconate,cyanocobalamin,citrus bioflavonoids extract,d-alpha-tocopheryl acid succinate,dibasic potassium phosphate,folic acid,fucus vesiculosus,inositol,iron amino acid chelate,magnesium phosphate pentahydrate,manganese sulfate monohydrate,nicotinamide,pyridoxine hydrochloride,retinol acetate,riboflavin,thiamine hydrochloride,vaccinium macrocarpon,zinc sulfate monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

herbs of gold pty ltd - ascorbic acid,biotin,calcium hydrogen phosphate,calcium pantothenate,colecalciferol,cyanocobalamin,citrus bioflavonoids extract,d-alpha-tocopheryl acid succinate,ferrous fumarate,folic acid,magnesium phosphate pentahydrate,manganese amino acid chelate,nicotinamide,potassium iodide,pyridoxine hydrochloride,retinol acetate,riboflavine,selenomethionine,sodium ascorbate,thiamine nitrate,zinc amino acid chelate -

Australia - English - Department of Health (Therapeutic Goods Administration)

blackmores ltd - magnesium phosphate pentahydrate, quantity: 90 mg (equivalent: magnesium, qty 18.6 mg); zinc amino acid chelate, quantity: 74.5 mg (equivalent: zinc, qty 14.9 mg); manganese amino acid chelate, quantity: 20 mg (equivalent: manganese, qty 2 mg); pyridoxine hydrochloride, quantity: 50 mg (equivalent: pyridoxine, qty 41.1 mg); retinol acetate, quantity: 0.8625 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; magnesium stearate; carnauba wax; soy polysaccharide; microcrystalline cellulose; hypromellose; macrogol 400; purified talc; zein; macrogol 8000; maize starch; gelatin; silicon dioxide; butylated hydroxytoluene; sucrose

Australia - English - Department of Health (Therapeutic Goods Administration)

blackmores ltd - zinc oxide, quantity: 1.24 mg (equivalent: zinc, qty 1 mg); ferrous fumarate, quantity: 3.804 mg; sodium ascorbate, quantity: 11.3 mg (equivalent: ascorbic acid, qty 10 mg); riboflavine, quantity: 0.5511 mg; nicotinamide, quantity: 5.994 mg; manganese amino acid chelate, quantity: 125 microgram (equivalent: manganese, qty 12.5 microgram); calcium pantothenate, quantity: 1.635 mg (equivalent: pantothenic acid, qty 1.5 mg); colecalciferol, quantity: 0.0025 mg; d-alpha-tocopheryl acid succinate, quantity: 12.4 mg; ascorbic acid, quantity: 10 mg; pyridoxine hydrochloride, quantity: 0.6493 mg; biotin, quantity: 25 microgram; cyanocobalamin, quantity: 0.75 microgram; folic acid, quantity: 50 microgram; calcium hydrogen phosphate, quantity: 17 mg (equivalent: calcium, qty 5 mg; equivalent: phosphorus, qty 3.87 mg); potassium iodide, quantity: 98.3 microgram (equivalent: iodine, qty 75 microgram); magnesium phosphate pentahydrate, quantity: 24.2 mg (equivalent: magnesium, qty 5 mg); thiamine nitrate, quantity: 0.3496 mg; retinol acetate, quantity: 0.2018 mg - tablet, chewable - excipient ingredients: colloidal anhydrous silica; xylitol; microcrystalline cellulose; hypromellose; stevia rebaudiana; magnesium stearate; maize starch; mono- and di- glycerides; silicon dioxide; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil; mannitol; flavour; gelatin; butylated hydroxytoluene - dietary supplement.

Australia - English - Department of Health (Therapeutic Goods Administration)

nature's care manufacture pty limited - ferrous fumarate, quantity: 3.8 mg (equivalent: iron, qty 1.25 mg); sodium ascorbate, quantity: 11.43 mg (equivalent: ascorbic acid, qty 10 mg); riboflavine, quantity: 0.5511 mg; nicotinamide, quantity: 6.0006 mg; manganese amino acid chelate, quantity: 0.12 mg (equivalent: manganese, qty 12 microgram); calcium pantothenate, quantity: 1.64 mg; colecalciferol, quantity: 0.0025 mg; d-alpha-tocopheryl acid succinate, quantity: 12.4 mg; ascorbic acid, quantity: 10 mg; pyridoxine hydrochloride, quantity: 0.6493 mg; biotin, quantity: 0.03 mg; cyanocobalamin, quantity: 0.0007 mg; folic acid, quantity: 0.05 mg; potassium iodide, quantity: 0.1 mg (equivalent: iodine, qty 75 microgram); calcium hydrogen phosphate dihydrate, quantity: 21.51 mg (equivalent: calcium, qty 5 mg); magnesium phosphate pentahydrate, quantity: 24.2 mg (equivalent: magnesium, qty 5 mg); thiamine nitrate, quantity: 0.3529 mg; retinol acetate, quantity: 0.2058 mg; zinc citrate dihydrate, quantity: 3.1 mg (equivalent: zinc, qty 1 mg) - tablet, chewable - excipient ingredients: sorbitol; xylitol; tartaric acid; beet red; isomalt; mannitol; magnesium stearate; povidone; acesulfame potassium; colloidal anhydrous silica; maize starch; silicon dioxide; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil; flavour; mono- and di- glycerides; maltodextrin; sodium citrate dihydrate; citric acid; starch sodium octenyl succinate - enhance/promote energy levels ; maintain/support healthy growth and development ; maintain/support (state vitamin/mineral/nutrient) levels in the body

United States - English - NLM (National Library of Medicine)

fresenius kabi norge as - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 80 mg in 1 ml - magnesium sulfate in water for injection is indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively.  when used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant.  however, other effective drugs are available for this purpose. intravenous magnesium should not be given to mothers with toxemia of pregnancy during the two hours preceding delivery.

United States - English - NLM (National Library of Medicine)

wg critical care, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 1 g in 100 ml - magnesium sulfate in 5% dextrose injection, usp is indicated for: magnesium sulfate in 5% dextrose injection is contraindicated in patients: risk summary magnesium sulfate in 5% dextrose injection is indicated in pregnant women for the prevention of eclampsia in women with preeclampsia and the treatment of seizures and prevention of recurrent seizures in women with eclampsia. fetal, neonatal, and maternal risks are discussed throughout the labeling. clinical considerations labor or delivery: magnesium sulfate in 5% dextrose injection is not approved for the treatment of pre-term labor. administration of magnesium sulfate in 5% dextrose injection to pregnant women longer than 5 to 7 days may lead to hypocalcemia and bone abnormalities in the developing fetus, including skeletal demineralization and osteopenia [see warnings and precautions (5.1)] . the use of intravenous magnesium in pregnant women increases human milk magnesium concentrations only slightly and oral absorption of magnesium by the infant is poor. the effect of intravenous magnesium on milk production is unknown. the developmental and health benefits to the neonate of breastfeeding should be considered along with the mother's clinical need for magnesium sulfate in 5% dextrose injection and any potential adverse effects on the breastfed infant from magnesium sulfate in 5% dextrose injection or from the underlying maternal condition. the safety and effectiveness of magnesium sulfate in 5% dextrose injection have been established for the prevention of eclampsia in adolescents with preeclampsia and the treatment of seizures and prevention of recurrent seizures in adolescents with eclampsia. dosing recommendation in pregnant adolescent patients are the same as for pregnant adult patients [see dosage and administration (2.2)] . magnesium is excreted solely by the kidneys. patients with severe renal impairment (urine output less than 100 ml per 4 hours) are at greater risk for increased magnesium concentrations that may lead to magnesium toxicity [see warnings and precautions (5.2) and clinical pharmacology (12.3)] . in patients with severe renal impairment, dosage reduction is recommended and the maximum recommended dosage is lower than patients with normal renal function [see dosage and administration (2.3)] .